TCI Wealth Advisors’s Precision BioSciences DTIL Stock Holding History

TCI Wealth Advisors’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13	Closed	-$302	–	768
2023 Q1	$302	Hold	13	–	–	﹤0.01%	2285
2022 Q4	$476	Sell	13 -4	-24%	-$158	﹤0.01%	2217
2022 Q3	$1K	Hold	17	–	–	﹤0.01%	2074
2022 Q2	$1K	Sell	17 -31	-65%	-$1.82K	﹤0.01%	2119
2022 Q1	$5K	Buy	48 +31	+182%	+$4.21K	﹤0.01%	1519
2021 Q4	$4K	Hold	17	–	–	﹤0.01%	1795
2021 Q3	$6K	Hold	17	–	–	﹤0.01%	1442
2021 Q2	$6K	Hold	17	–	–	﹤0.01%	1299
2021 Q1	$5K	Hold	17	–	–	﹤0.01%	1244
2020 Q4	$4K	Sell	17 -23	-58%	-$5.64K	﹤0.01%	949
2020 Q3	$7K	Hold	40	–	–	﹤0.01%	664
2020 Q2	$10K	Sell	40 -3	-7%	-$657	﹤0.01%	570
2020 Q1	$8K	Buy	43 +23	+115%	+$6.02K	﹤0.01%	613
2019 Q4	$8K	Hold	20	–	–	﹤0.01%	746
2019 Q3	$5K	Buy	+20	New	+$6.51K	﹤0.01%	795

Other funds holding DTIL

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

TCI Wealth Advisors's DTIL Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 13 shares — an estimated $302 sold.

TCI Wealth Advisors first reported a position in DTIL in Q3 2019 and held it in 15 quarters. The position peaked at $10K in Q2 2020. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

TCI Wealth Advisors reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 13 Precision BioSciences shares in Q2 2023, an estimated $302.
TCI Wealth Advisors first reported a position in Precision BioSciences in Q3 2019 and held it in 15 quarters.
TCI Wealth Advisors's Precision BioSciences position peaked at $10K in Q2 2020.
77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.